148 related articles for article (PubMed ID: 15183654)
21. Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis.
Grenda DS; Johnson SE; Mayer JR; McLemore ML; Benson KF; Horwitz M; Link DC
Blood; 2002 Nov; 100(9):3221-8. PubMed ID: 12384420
[TBL] [Abstract][Full Text] [Related]
22. Severe congenital neutropenia with elastase, neutrophil expressed (ELANE) gene mutation in a Tanzanian child.
Shoo A; Swai P; Kindole C; Ngailo E; Godfrey E; Massawe E; Warren AJ; Luzzatto L
Br J Haematol; 2022 Mar; 196(5):1271-1274. PubMed ID: 34725814
[No Abstract] [Full Text] [Related]
23. Congenital neutropenia.
Ancliff PJ
Blood Rev; 2003 Dec; 17(4):209-16. PubMed ID: 14556775
[TBL] [Abstract][Full Text] [Related]
24. Ela2 mutations and clinical manifestations in familial congenital neutropenia.
Shiohara M; Shigemura T; Saito S; Tanaka M; Yanagisawa R; Sakashita K; Asada H; Ishii E; Koike K; Chin M; Kobayashi M; Koike K
J Pediatr Hematol Oncol; 2009 May; 31(5):319-24. PubMed ID: 19415009
[TBL] [Abstract][Full Text] [Related]
25. Bone mineralization and turnover in children with congenital neutropenia, and its relationship to treatment with recombinant human granulocyte-colony stimulating factor.
Fewtrell MS; Kinsey SE; Williams DM; Bishop NJ
Br J Haematol; 1997 Jun; 97(4):734-6. PubMed ID: 9217170
[TBL] [Abstract][Full Text] [Related]
26. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.
Schroten H; Roesler J; Breidenbach T; Wendel U; Elsner J; Schweitzer S; Zeidler C; Burdach S; Lohmann-Matthes ML; Wahn V
J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175
[TBL] [Abstract][Full Text] [Related]
27. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b.
Calderwood S; Kilpatrick L; Douglas SD; Freedman M; Smith-Whitley K; Rolland M; Kurtzberg J
Blood; 2001 Jan; 97(2):376-82. PubMed ID: 11154211
[TBL] [Abstract][Full Text] [Related]
28. Severe congenital neutropenia.
Welte K; Zeidler C; Dale DC
Semin Hematol; 2006 Jul; 43(3):189-95. PubMed ID: 16822461
[TBL] [Abstract][Full Text] [Related]
29. Osteoporosis in severe congenital neutropenia treated with granulocyte colony-stimulating factor.
Bishop NJ; Williams DM; Compston JC; Stirling DM; Prentice A
Br J Haematol; 1995 Apr; 89(4):927-8. PubMed ID: 7539627
[TBL] [Abstract][Full Text] [Related]
30. Glycogen storage disease type Ib: infectious complications and measures for prevention.
Wendel U; Schroten H; Burdach S; Wahn V
Eur J Pediatr; 1993; 152 Suppl 1():S49-51. PubMed ID: 7686491
[TBL] [Abstract][Full Text] [Related]
31. The many causes of severe congenital neutropenia.
Dale DC; Link DC
N Engl J Med; 2009 Jan; 360(1):3-5. PubMed ID: 19118300
[No Abstract] [Full Text] [Related]
32. Different clinical phenotypes in familial severe congenital neutropenia cases with same mutation of the ELANE gene.
Cho HK; Jeon IS
J Korean Med Sci; 2014 Mar; 29(3):452-5. PubMed ID: 24616599
[TBL] [Abstract][Full Text] [Related]
33. Neonatal neutropenia: what diagnostic evaluation is needed and when is treatment recommended?
Del Vecchio A; Christensen RD
Early Hum Dev; 2012 May; 88 Suppl 2():S19-24. PubMed ID: 22633505
[TBL] [Abstract][Full Text] [Related]
34. Genetic insights into congenital neutropenia.
Klein C; Welte K
Clin Rev Allergy Immunol; 2010 Feb; 38(1):68-74. PubMed ID: 19440858
[TBL] [Abstract][Full Text] [Related]
35. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy.
Freedman MH; Bonilla MA; Fier C; Bolyard AA; Scarlata D; Boxer LA; Brown S; Cham B; Kannourakis G; Kinsey SE; Mori PG; Cottle T; Welte K; Dale DC
Blood; 2000 Jul; 96(2):429-36. PubMed ID: 10887102
[TBL] [Abstract][Full Text] [Related]
36. Cyclic neutropenia.
Dale DC; Bolyard AA; Aprikyan A
Semin Hematol; 2002 Apr; 39(2):89-94. PubMed ID: 11957190
[TBL] [Abstract][Full Text] [Related]
37. Improvement of neutropenia and neutrophil dysfunction by granulocyte colony-stimulating factor in a patient with glycogen storage disease type Ib.
Ishiguro A; Nakahata T; Shimbo T; Amano Y; Yasui K; Koike K; Komiyama A
Eur J Pediatr; 1993 Jan; 152(1):18-20. PubMed ID: 7680314
[TBL] [Abstract][Full Text] [Related]
38. Effect of granulocyte colony-stimulating factor on preeclampsia-associated neonatal neutropenia.
La Gamma EF; Alpan O; Kocherlakota P
J Pediatr; 1995 Mar; 126(3):457-9. PubMed ID: 7532709
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics of severe congenital neutropenia caused by novel ELANE gene mutations.
Shu Z; Li XH; Bai XM; Zhang ZY; Jiang LP; Tang XM; Zhao XD
Pediatr Infect Dis J; 2015 Feb; 34(2):203-7. PubMed ID: 25162927
[TBL] [Abstract][Full Text] [Related]
40. Congenital and acquired neutropenia.
Berliner N; Horwitz M; Loughran TP
Hematology Am Soc Hematol Educ Program; 2004; ():63-79. PubMed ID: 15561677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
